Cargando…

Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial–Type 1 (DPT-1) oral insulin trial

OBJECTIVE: To evaluate the long-term intervention effects of oral insulin on the development of type 1 diabetes and to assess the rate of progression to type 1 diabetes before and after oral insulin treatment was stopped in the Diabetes Prevention Trial–Type 1 (DPT-1). RESEARCH DESIGN AND METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vehik, Kendra, Cuthbertson, David, Ruhlig, Holly, Schatz, Desmond A., Peakman, Mark, Krischer, Jeffrey P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120180/ https://www.ncbi.nlm.nih.gov/pubmed/21610124 http://dx.doi.org/10.2337/dc11-0523

Ejemplares similares

Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood
por: Vehik, Kendra, et al.
Publicado: (2011)

Feature ranking based on synergy networks to identify prognostic markers in DPT-1
por: Adl, Amin Ahmadi, et al.
Publicado: (2013)

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
por: Sosenko, Jay M., et al.
Publicado: (2020)

A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants
por: Sosenko, Jay M., et al.
Publicado: (2011)

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1)
por: Sosenko, Jay M., et al.
Publicado: (2010)

Performance of HbA(1c) as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth
por: Vehik, Kendra, et al.
Publicado: (2012)

Development of Autoantibodies in the TrialNet Natural History Study
por: Vehik, Kendra, et al.
Publicado: (2011)

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Orban, Tihamer, et al.
Publicado: (2009)

Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 Diabetes
por: Xu, Ping, et al.
Publicado: (2014)

Impact of Diabetes Susceptibility Loci on Progression From Pre-Diabetes to Diabetes in At-Risk Individuals of the Diabetes Prevention Trial–Type 1 (DPT-1)
por: Butty, Vincent, et al.
Publicado: (2008)

Learning From Past Failures of Oral Insulin Trials
por: Michels, Aaron W., et al.
Publicado: (2018)

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants
por: Sosenko, Jay M., et al.
Publicado: (2010)

A Rule-Based Prognostic Model for Type 1 Diabetes by Identifying and Synthesizing Baseline Profile Patterns
por: Lin, Ying, et al.
Publicado: (2014)

Oral Insulin
por: Kalra, Sanjay, et al.
Publicado: (2010)

Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
por: Assfalg, Robin, et al.
Publicado: (2021)

Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial–Type 1 (DPT-1) Are Often Asymptomatic With Normal A1C at Diabetes Onset
por: Triolo, Taylor M., et al.
Publicado: (2009)

Label‐free proteomic dissection on dptP‐deletion mutant uncovers dptP involvement in strain growth and daptomycin tolerance of Streptomyces roseosporus
por: Zhang, Dan, et al.
Publicado: (2020)

Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM‐INSULIN randomized trial
por: Leiter, Lawrence A., et al.
Publicado: (2017)

A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes
por: Lin, Shuo, et al.
Publicado: (2018)

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2019)

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants
por: Sosenko, Jay M., et al.
Publicado: (2013)

2442 Listening for empathy: Audio narratives in DPT curriculum as a model for interprofessional education
por: Farroni, Jeffrey S., et al.
Publicado: (2018)

Material design for oral insulin delivery
por: Ji, Kangfan, et al.
Publicado: (2023)

Insulin Inclusion into a Tragacanth Hydrogel: An Oral Delivery System for Insulin
por: Nur, Mokhamad, et al.
Publicado: (2018)

A robust and transformation-free joint model with matching and regularization for metagenomic trajectory and disease onset
por: Li, Qian, et al.
Publicado: (2022)

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2008)

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
por: Bretzel, Reinhard G., et al.
Publicado: (2009)

Why Are C-Section Deliveries Linked to Childhood Type 1 Diabetes?
por: Vehik, Kendra, et al.
Publicado: (2012)

Thoracoscopic mediastinal tumor resection by subxiphoid approach—dual port thymectomy plus one (DPT+1)
por: Ito, Atsushi, et al.
Publicado: (2019)

Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin
por: Sun, Shaoping, et al.
Publicado: (2011)

Nanolayer encapsulation of insulin-chitosan complexes improves efficiency of oral insulin delivery
por: Song, Lei, et al.
Publicado: (2014)

Effects of Oral Glucose Load on Endothelial Function and on Insulin and Glucose Fluctuations in Healthy Individuals
por: Major-Pedersen, A., et al.
Publicado: (2008)

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
por: Zinman, Bernard, et al.
Publicado: (2012)

Multifunctional Composite Microcapsules for Oral Delivery of Insulin
por: Sun, Shaoping, et al.
Publicado: (2016)

Intestinal mucoadhesive devices for oral delivery of insulin
por: Banerjee, Amrita, et al.
Publicado: (2016)

Acciones de enfermería en el manejo del biológico D.P.T.
por: García Merino, Leticia
Publicado: (1988)

Age-appropriate vaccination against measles and DPT-3 in India – closing the gaps
por: Awofeso, Niyi, et al.
Publicado: (2013)

Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study
por: Sosenko, Jay M., et al.
Publicado: (2011)

Type 2 diabetes quality of life patients treated with insulin and oral hypoglycemic medication
por: Fal, Andrzej M., et al.
Publicado: (2010)

Insulin-Loaded Barium Salt Particles Facilitate Oral Delivery of Insulin in Diabetic Rats
por: Zaman, Rahela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_apiunvdeqkss5e8vpc0j07atf2